Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Caroline A. Drukker"'
Autor:
Josefien P. van Olmen, Veerle CM. Geurts, Marie-Jeanne TFD. Vrancken Peeters, Caroline A. Drukker, Marcel PM. Stokkel, Marleen Kok, Frederieke H. van Duijnhoven
Publikováno v:
Breast, Vol 78, Iss , Pp 103822- (2024)
Background: Guidelines recommend systemic therapy for stage I HER2+ breast cancer (BC). Neoadjuvant systemic treatment (NAST) allows response-guided adjuvant treatment. However, prior to NAST only clinical nodal staging is available, risking undertre
Externí odkaz:
https://doaj.org/article/c83b28677bb04a91a21da8b4b91658e4
Autor:
Josefien P. van Olmen, Chaja F. Jacobs, Sanne A.L. Bartels, Claudette E. Loo, Joyce Sanders, Marie-Jeanne T.F.D. Vrancken Peeters, Caroline A. Drukker, Frederieke H. van Duijnhoven, Marleen Kok
Publikováno v:
Breast, Vol 75, Iss , Pp 103726- (2024)
Objective: This study aims to evaluate the response to and surgical benefits of neoadjuvant endocrine therapy (NET) in ER+/HER2-breast cancer patients who are clinically high risk, but genomic low risk according to the 70-gene signature (MammaPrint).
Externí odkaz:
https://doaj.org/article/704ad2649c1245a2bc5b540ca828061f
Autor:
Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker
Publikováno v:
Breast, Vol 71, Iss , Pp 143-149 (2023)
Purpose: Tailored recommendation for adjuvant chemotherapy in breast cancer patients is of great importance. This survey assessed agreement among oncologists on risk assessment and chemotherapy recommendation, the impact of adding the 70-gene signatu
Externí odkaz:
https://doaj.org/article/68f1f4a4ff414d15974d53b8922bcb3a
Autor:
Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens, Samuel Aparicio, Ayse Bassez, Ake Borg, Jane Brock, Annegien Broeks, Carlos Caldas, Fatima Cardoso, Maxim De Schepper, Mauro Delorenzi, Caroline A. Drukker, Annuska M. Glas, Andrew R. Green, Edoardo Isnaldi, Jórunn Eyfjörð, Hazem Khout, Stian Knappskog, Savitri Krishnamurthy, Sunil R. Lakhani, Anita Langerod, John W. M. Martens, Amy E. McCart Reed, Leigh Murphy, Stefan Naulaerts, Serena Nik-Zainal, Ines Nevelsteen, Patrick Neven, Martine Piccart, Coralie Poncet, Kevin Punie, Colin Purdie, Emad A. Rakha, Andrea Richardson, Emiel Rutgers, Anne Vincent-Salomon, Peter T. Simpson, Marjanka K. Schmidt, Christos Sotiriou, Paul N. Span, Kiat Tee Benita Tan, Alastair Thompson, Stefania Tommasi, Karen Van Baelen, Marc Van de Vijver, Steven Van Laere, Laura van’t Veer, Giuseppe Viale, Alain Viari, Hanne Vos, Anke T. Witteveen, Hans Wildiers, Giuseppe Floris, Abhishek D. Garg, Ann Smeets, Diether Lambrechts, Elia Biganzoli, François Richard, Christine Desmedt
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Obesity is associated with an increased risk of developing breast cancer (BC) and worse prognosis in BC patients, yet its impact on BC biology remains understudied in humans. This study investigates how the biology of untreated primary BC di
Externí odkaz:
https://doaj.org/article/449fce543ad84736bc9d60953aa2df60
Autor:
Daniël J. van de Berg, Anke M. J. Kuijpers, Anton F. Engelsman, Caroline A. Drukker, Hanneke M. van Santen, Sheila C. E. J. Terwisscha van Scheltinga, A. S. Paul van Trotsenburg, Christiaan F. Mooij, Menno R. Vriens, Els J. M. Nieveen van Dijkum, Joep P. M. Derikx
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
IntroductionPediatric thyroid carcinoma is a rare malignancy and data on long-term oncological outcomes are sparse. The aim of this study was to describe the long-term oncological outcomes of pediatric papillary thyroid carcinoma (PTC) and follicular
Externí odkaz:
https://doaj.org/article/0fc682d2a83e4972894fd2b5414fdcd8
Autor:
Sonja B. Vliek, Florentine S. Hilbers, Agnes Jager, Valesca P. Retèl, Jolien M. Bueno de Mesquita, Caroline A. Drukker, Sanne C. Veltkamp, Anneke M. Zeillemaker, Emiel J. Rutgers, Harm van Tinteren, Wim H. van Harten, Laura J. van 't Veer, Marc J. van de Vijver, Sabine C. Linn
Publikováno v:
European Journal of Cancer, 175, 169-179. Elsevier Limited
European Journal of Cancer, 175, 169-179. Elsevier Ltd.
European journal of cancer, 175, 169-179. Elsevier
European Journal of Cancer, 175, 169-179. Elsevier Ltd.
European journal of cancer, 175, 169-179. Elsevier
Introduction: Prognostic gene expression signatures can be used in combination with classical clinicopathological factors to guide adjuvant chemotherapy decisions in ER-positive, HER2-negative breast cancer. However, long-term outcome data after intr
Autor:
Josephine M.N. Lopes Cardozo, Caroline A. Drukker, Emiel J.T. Rutgers, Marjanka K. Schmidt, Annuska M. Glas, Anke Witteveen, Fatima Cardoso, Martine Piccart, Laura J. Esserman, Coralie Poncet, Laura J. van 't Veer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(12)
PURPOSE Patients with 70-gene signature ultralow-risk breast cancers have shown excellent survival in historic cohorts, including randomized trials. The ultralow-risk subgroup was characterized to help avoid overtreatment. We evaluated outcomes of ul
Autor:
Josephine M.N. Lopes Cardozo, Sherylene E. Veira, Laila Ait Hassou, Aimé Lambert Uwimana, Ivana Božović-Spasojević, Jan Bogaerts, Fatima Cardoso, Marjanka K. Schmidt, Emiel J.T. Rutgers, Coralie Poncet, Caroline A. Drukker
Publikováno v:
European Journal of Cancer. 175:S64
Autor:
Caroline A, Drukker, Marjanka K, Schmidt, Thijs, van Dalen, Jacobus J M, van der Hoeven, Sabine C, Linn, Emiel J T, Rutgers
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 158
Gene expression classifiers such as the 70-gene signature that reflect the biology of breast tumours have started to find their way into daily clinical practice. Several retrospective validation studies in breast cancer have established the prognosti